Purchase Order 75N98026P00981

<p>This is a firm fixed-price purchase order contract awarded by the National Human Genome Research Institute (NHGRI), a civilian agency, to Inbiomedic Sac, a for-profit limited liability company based in Peru, for $22,771.64 in research services. The contract has a period of performance through November 15, 2025 and does not have a set-aside designation. No additional information about larger contract vehicles or subcontractors is provided.</p>

<p>The National Human Genome Research Institute issued a $149,618.50 delivery order to Illumina, Inc., on September 1, 2017, for genetic sequencing and genomic analysis technologies.</p> <p>Place of performance is North Bethesda, MD. The order has a firm fixed-price structure with an ultimate completion date of September 30, 2017.</p>

<p>The National Human Genome Research Institute issued a $5,450.23 delivery order to Illumina, Inc. on August 15, 2018, for genetic sequencing and genomic analysis technologies.</p> <p>Place of performance is North Bethesda, MD. The order carries a firm fixed-price structure and an ultimate completion date of September 14, 2018.</p>

<p>The National Human Genome Research Institute issued a $98,905.32 delivery order to Illumina, Inc. on August 22, 2019, for genetic sequencing and genomic analysis technologies.</p> <p>Place of performance is Bethesda, MD 20892. The order is firm fixed-price with an ultimate completion date of September 2, 2020. No set-aside was used.</p>

The National Human Genome Research Institute issued a $30,186 delivery order to Science Management &amp; Engineering, Inc., a minority-owned small disadvantaged business, on January 16, 2020, under the GSA Scientific Equipment and Services (FSS-66) schedule. Place of performance is Montgomery Village, MD 20877. The order has a firm fixed price and an ultimate completion date of April 21, 2020. The work supports science management and engineering services within the NHGRI's research portfolio.

<p>The National Human Genome Research Institute issued a $122,145.01 delivery order to Illumina, Inc. on September 15, 2017, for genetic sequencing and genomic analysis technologies.</p> <p>Place of performance is Bethesda, MD 20892. The order has a firm fixed-price structure with an ultimate completion date of December 15, 2017. No set-aside was used.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Eurofins Genomics LLC for $14,975.00 on December 13, 2016, with a firm fixed price for research studies. Place of performance is Bethesda, Maryland. The order was not set-aside and carries an ultimate completion date of January 11, 2021.</p>

<p>The National Human Genome Research Institute issued a $24,926.45 delivery order to Illumina, Inc. on September 19, 2019, under a firm fixed-price structure.</p> <p>Place of performance is Bethesda, MD. The order was due for completion on September 2, 2020. No set-aside was applied to this delivery order.</p>

<p>The National Human Genome Research Institute issued a purchase order to Pacific Biosciences Of California, Inc. on July 7, 2017, for $4,525.00 under firm fixed-price terms. Work is to be performed in North Bethesda, Maryland, with an ultimate completion date of August 6, 2017. The purchase order covers sequencing consumables or reagents supporting the institute's genomic research operations.</p>

<p>The National Human Genome Research Institute issued a purchase order to Medical Neurogenetics, LLC on February 6, 2018, for clinical genetic testing with a ceiling value of $249,481.00. Work is performed in Bethesda, Maryland. The order was completed by November 2, 2023. Pricing is firm fixed price with no small business set-aside applied.</p>